MII IG Kerndatensatz-Modul Seltene Erkrankungen
2027.0.0-ballot - Germany

This page is part of the MII Implementation Guide Seltene Erkrankungen (v2027.0.0-ballot: 2027 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: Hereditäres Mamma- und Ovarialkarzinom-Syndrom

Raw xml | Download


<Condition xmlns="http://hl7.org/fhir">
  <id value="mii-exa-seltene-example-brca1-genetic-diagnosis"/>
  <meta>
    <profile
             value="https://www.medizininformatik-initiative.de/fhir/ext/modul-seltene/StructureDefinition/mii-pr-seltene-genetic-diagnosis|2027.0.0-ballot"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="extensions"/>
    <div xml:lang="en" lang="en"><hr/><p><b>English</b></p><hr/><p class="res-header-id"><b>Generated Narrative: Condition mii-exa-seltene-example-brca1-genetic-diagnosis</b></p><a name="mii-exa-seltene-example-brca1-genetic-diagnosis"> </a><a name="hcmii-exa-seltene-example-brca1-genetic-diagnosis"> </a><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px"/><p style="margin-bottom: 0px">Profile: <a href="StructureDefinition-mii-pr-seltene-genetic-diagnosis.html">MII PR SE Genetic Diagnosis</a> version: 2027.0.0-ballot</p></div><p><b>Condition Asserted Date</b>: 2024-11-01</p><p><b>clinicalStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/condition-clinical active}">Active</span></p><p><b>verificationStatus</b>: <span title="Codes:{http://terminology.hl7.org/CodeSystem/condition-ver-status confirmed}">Confirmed</span></p><p><b>category</b>: <span title="Codes:{http://snomed.info/sct 782964007}">Genetic disease</span></p><p><b>code</b>: <span title="Codes:{http://omim.org 604370}, {http://snomed.info/sct 718220008}, {http://www.orpha.net 145}">Hereditäres Mamma- und Ovarialkarzinom-Syndrom (BRCA1)</span></p><p><b>subject</b>: <a href="Patient-mii-exa-seltene-patient.html">Max Mustermann (official) Male, DoB: 1990-01-01 ( http://test-krankenhaus.de/fhir/sid/patienten#12345)</a></p><p><b>recordedDate</b>: 2024-11-01</p><blockquote><p><b>evidence</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 106221001}">Genetic finding</span></p><p><b>detail</b>: <a href="Observation-mii-exa-seltene-molgen-variant-brca1-pathogenic.html">Observation Genetic variant assessment</a></p></blockquote><blockquote><p><b>evidence</b></p><p><b>code</b>: <span title="Codes:{http://snomed.info/sct 405824009}">Genetic test</span></p><p><b>detail</b>: <a href="DiagnosticReport-mii-exa-seltene-molgen-brca-panel.html">Diagnostic Report for 'Master HL7 genetic variant reporting panel' for '-&gt;Max Mustermann (official) Male, DoB: 1990-01-01 ( http://test-krankenhaus.de/fhir/sid/patienten#12345)'</a></p></blockquote><p><b>note</b>: </p><blockquote><div><p>Pathogene Variante c.68_69del (p.Glu23Valfs*17) in BRCA1 nachgewiesen. Penetranz für Mammakarzinom bis 80 Jahre: 72%.</p>
</div></blockquote></div>
  </text>
  <extension
             url="http://hl7.org/fhir/StructureDefinition/condition-assertedDate">
    <valueDateTime value="2024-11-01"/>
  </extension>
  <clinicalStatus>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/condition-clinical"/>
      <code value="active"/>
    </coding>
  </clinicalStatus>
  <verificationStatus>
    <coding>
      <system
              value="http://terminology.hl7.org/CodeSystem/condition-ver-status"/>
      <code value="confirmed"/>
    </coding>
  </verificationStatus>
  <category>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="782964007"/>
      <display value="Genetic disease"/>
    </coding>
  </category>
  <code>
    <coding>
      <system value="http://omim.org"/>
      <version value="2024"/>
      <code value="604370"/>
      <display value="Breast-ovarian cancer, familial, 1"/>
    </coding>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="718220008"/>
      <display value="Hereditary breast and ovarian cancer syndrome"/>
    </coding>
    <coding>
      <system value="http://www.orpha.net"/>
      <code value="145"/>
      <display value="Hereditary breast and/or ovarian cancer syndrome"/>
    </coding>
    <text value="Hereditäres Mamma- und Ovarialkarzinom-Syndrom (BRCA1)"/>
  </code>
  <subject>🔗 
    <reference value="Patient/mii-exa-seltene-patient"/>
  </subject>
  <recordedDate value="2024-11-01"/>
  <evidence>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="106221001"/>
        <display value="Genetic finding"/>
      </coding>
    </code>
    <detail>🔗 
      <reference
                 value="Observation/mii-exa-seltene-molgen-variant-brca1-pathogenic"/>
    </detail>
  </evidence>
  <evidence>
    <code>
      <coding>
        <system value="http://snomed.info/sct"/>
        <code value="405824009"/>
        <display value="Genetic test"/>
      </coding>
    </code>
    <detail>🔗 
      <reference value="DiagnosticReport/mii-exa-seltene-molgen-brca-panel"/>
    </detail>
  </evidence>
  <note>
    <text
          value="Pathogene Variante c.68_69del (p.Glu23Valfs*17) in BRCA1 nachgewiesen. Penetranz für Mammakarzinom bis 80 Jahre: 72%."/>
  </note>
</Condition>